introducing
TECHNOLOGY & RARE NEUROLOGICAL DISEASES SYMPOSIUM
presented by
The University of Rochester, a national leader in rare diseases clinical research and therapeutic development, is hosting a one-day symposium on novel applications of technology to accelerate the development of new therapeutics for patients with rare neurological disorders.
Regional and national leaders in rare diseases, health technologies, and clinical trials will demonstrate how to leverage new tools and technologies to enhance patient partnership, reduce the burden of participation in clinical research, and accelerate development of new therapeutics.
introducing
TECHNOLOGY & RARE NEUROLOGICAL DISEASES SYMPOSIUM
presented by
The University of Rochester, a national leader in rare diseases clinical research and therapeutic development, is hosting a one-day symposium on novel applications of technology to accelerate the development of new therapeutics for patients with rare neurological disorders.
Regional and national leaders in rare diseases, health technologies, and clinical trials will demonstrate how to leverage new tools and technologies to enhance patient partnership, reduce the burden of participation in clinical research, and accelerate development of new therapeutics.
Friday, May 12, 2017
7:30am - 3:45pm
Helen Wood Hall Auditorium
TRNDS Speakers
Regional and national leaders in rare diseases, health technologies and clinical trials
Erika F. Augustine
Associate Director, URMC Center for Human Experimental Therapeutics
Arthur Combs
Chief Medical Officer, mc10
Ray Dorsey
Director, URMC Center for Human Experimental Therapeutics
Tim Ehrhard
Director of Information Technology, National Organization for Rare Disorders
Jennifer Farmer
Executive Director, Friedreich’s Ataxia Research Alliance
Luke Gelinas
Petrie-Flom Center/Harvard Catalyst Fellow, Harvard Law School
Dave Jacob
CEO, ThinkGenetic
Karl Kieburtz
Director, URMC Clinical & Translational Science Institute
Deborah Kilpatrick
Chief Executive Officer, Evidation Health
Craig H. Lipset
Head of Clinical Innovation, Pfizer
Michael O’Brien
President, Clinical Trials Division AMC Health
Spyros Papapetropoulos
VP & Global Head of Neurodegeration, Movement Disorders & Clinical Research Transformation, TEVA
Maria Picone
Founder, TREND Community
Jane Rhodes
Senior Director, New Initiatives, Innovation Hub at Biogen
Kristin Schneeman
Director of Programs, FasterCures
Ira Shoulson
Director, Program for Regulatory Science & Medicine Georgetown University
Sandra Shpilberg
Founder & CEO, Seeker Health
Komathi Stem
Founder & CEO. monARC Bionetworks, Inc.
Wendy White
Board Chairman, Global Genes Senior VP of Rare Disease, Dohmen Life Science Services
